ESC Premium Access

Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study

Congress Session

About the speaker

Doctor Erik Klok

Leiden University Medical Centre, Leiden (Netherlands (The))
3 presentations
0 follower

3 more presentations in this session

State of the Art - Optimizing the prevention of venous thromboembolism

Speaker: Professor A. Spyropoulos (New York, US)


Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Speaker: Doctor Y. Yamashita (Kyoto, JP)


Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial

Speaker: Doctor A. Kalayci Karabay (Boston, US)


Access the full session

Progress in anticoagulation for venous thromboembolism

Speakers: Doctor E. Klok, Professor A. Spyropoulos, Doctor Y. Yamashita, Doctor A. Kalayci Karabay

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk